JP2018510202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018510202A5 JP2018510202A5 JP2017551710A JP2017551710A JP2018510202A5 JP 2018510202 A5 JP2018510202 A5 JP 2018510202A5 JP 2017551710 A JP2017551710 A JP 2017551710A JP 2017551710 A JP2017551710 A JP 2017551710A JP 2018510202 A5 JP2018510202 A5 JP 2018510202A5
- Authority
- JP
- Japan
- Prior art keywords
- nhq
- membered
- nhc
- heterocycle
- partially
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000623 heterocyclic group Chemical group 0.000 claims 30
- 229920006395 saturated elastomer Polymers 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 20
- 125000005842 heteroatom Chemical group 0.000 claims 17
- 229910052757 nitrogen Inorganic materials 0.000 claims 17
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 17
- 125000003118 aryl group Chemical group 0.000 claims 16
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 6
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 5
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 5
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 5
- 229910052717 sulfur Inorganic materials 0.000 claims 5
- 239000004599 antimicrobial Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 125000001963 4 membered heterocyclic group Chemical group 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 125000002619 bicyclic group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- ORFOPKXBNMVMKC-DWVKKRMSSA-N ceftazidime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 ORFOPKXBNMVMKC-DWVKKRMSSA-N 0.000 claims 2
- 229960000484 ceftazidime Drugs 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003781 beta lactamase inhibitor Substances 0.000 claims 1
- 229940126813 beta-lactamase inhibitor Drugs 0.000 claims 1
- -1 cyclofluoroalkyl Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical compound C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 claims 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- 150000003952 β-lactams Chemical group 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305473.9 | 2015-03-31 | ||
| EP15305473.9A EP3075733A1 (en) | 2015-03-31 | 2015-03-31 | Novel heterocyclic compounds and their use in preventing or treating bacterial infections |
| EP16305073.5 | 2016-01-26 | ||
| EP16305073 | 2016-01-26 | ||
| PCT/EP2016/056847 WO2016156348A1 (en) | 2015-03-31 | 2016-03-30 | Novel heterocyclic compounds and their use in preventing or treating bacterial infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018510202A JP2018510202A (ja) | 2018-04-12 |
| JP2018510202A5 true JP2018510202A5 (enExample) | 2019-04-11 |
Family
ID=55642467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017551710A Pending JP2018510202A (ja) | 2015-03-31 | 2016-03-30 | 新規の複素環化合物及び細菌感染を予防又は治療する際のそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10072006B2 (enExample) |
| EP (1) | EP3277686B1 (enExample) |
| JP (1) | JP2018510202A (enExample) |
| KR (1) | KR20170132301A (enExample) |
| CN (1) | CN107531708A (enExample) |
| AU (1) | AU2016239209A1 (enExample) |
| BR (1) | BR112017020796A2 (enExample) |
| CA (1) | CA2980085A1 (enExample) |
| CL (1) | CL2017002451A1 (enExample) |
| MX (1) | MX2017012535A (enExample) |
| RU (1) | RU2017133660A (enExample) |
| TW (1) | TW201643164A (enExample) |
| WO (1) | WO2016156348A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2983674A1 (en) * | 2015-05-07 | 2016-11-10 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
| KR102537340B1 (ko) * | 2016-09-16 | 2023-05-26 | 엔타시스 테라퓨틱스 리미티드 | 베타-락타마제 억제제 화합물 |
| EP3300736B1 (en) * | 2016-09-30 | 2021-05-05 | Mutabilis | Composition comprising antibiotic compound and an heterocyclic compound and their use in preventing or treating bacterial infections |
| EP3357924A1 (en) * | 2017-02-06 | 2018-08-08 | Mutabilis | Novel heterocyclic compounds and their use in preventing or treating bacterial infections |
| FI3833665T3 (fi) | 2018-08-09 | 2023-10-09 | Antabio Sas | Diatsabisyklo-oktanoneja seriini-beeta-laktamaasien inhibiittoreina |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| CN109942579B (zh) * | 2019-04-18 | 2021-06-22 | 成都千禧莱医药科技有限公司 | β-内酰胺酶抑制剂含脲双环化合物及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2936798B1 (fr) * | 2008-10-03 | 2012-09-28 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
| AR090539A1 (es) * | 2012-04-02 | 2014-11-19 | Astrazeneca Ab | COMPUESTOS INHIBIDORES DE b LACTAMASA |
| WO2014141132A1 (en) * | 2013-03-14 | 2014-09-18 | Naeja Pharmaceutical Inc. | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS |
-
2016
- 2016-03-30 EP EP16712867.7A patent/EP3277686B1/en active Active
- 2016-03-30 CA CA2980085A patent/CA2980085A1/en not_active Abandoned
- 2016-03-30 TW TW105110140A patent/TW201643164A/zh unknown
- 2016-03-30 JP JP2017551710A patent/JP2018510202A/ja active Pending
- 2016-03-30 WO PCT/EP2016/056847 patent/WO2016156348A1/en not_active Ceased
- 2016-03-30 KR KR1020177031505A patent/KR20170132301A/ko not_active Withdrawn
- 2016-03-30 BR BR112017020796-6A patent/BR112017020796A2/pt not_active Application Discontinuation
- 2016-03-30 MX MX2017012535A patent/MX2017012535A/es unknown
- 2016-03-30 US US15/563,519 patent/US10072006B2/en active Active
- 2016-03-30 RU RU2017133660A patent/RU2017133660A/ru not_active Application Discontinuation
- 2016-03-30 CN CN201680019934.7A patent/CN107531708A/zh active Pending
- 2016-03-30 AU AU2016239209A patent/AU2016239209A1/en not_active Abandoned
-
2017
- 2017-09-28 CL CL2017002451A patent/CL2017002451A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018510202A5 (enExample) | ||
| JP2018510198A5 (enExample) | ||
| HRP20250099T1 (hr) | Agonisti receptora glp-1 i njihova upotreba | |
| JP2019031560A5 (enExample) | ||
| JP2016516699A5 (enExample) | ||
| JP2018504393A5 (enExample) | ||
| JP2019519586A5 (enExample) | ||
| JP2006507326A5 (enExample) | ||
| RU2014105624A (ru) | Соединения индазола, способ их применения и фармацевтическая композиция | |
| JP2016536364A5 (enExample) | ||
| JP2007519694A5 (enExample) | ||
| JP2003500404A5 (enExample) | ||
| RU2017133660A (ru) | Новые гетероциклические соединения и их применение в профилактике или лечении бактериальных инфекций | |
| RU2348628C2 (ru) | Замещенные циклопропильной группой оксазолидиноновые антибиотики и их производные | |
| HRP20201985T1 (hr) | Piridonski spoj kao c-met inhibitor | |
| JP2020511547A5 (enExample) | ||
| AR062299A1 (es) | Derivados de bencimidazol | |
| FR2673427B1 (fr) | Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant. | |
| JP2016511274A5 (enExample) | ||
| JP2020506192A5 (enExample) | ||
| JP2018503661A5 (enExample) | ||
| JP2017500321A5 (enExample) | ||
| PH12020550761A1 (en) | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND MEDICAL USE THEREOF | |
| JP2005529842A5 (enExample) | ||
| JP2005533052A5 (enExample) |